Hospital Canselor Tuanku Muhriz UKM

Cheras, Kuala Lumpur 56000

2 studies enrolling now · 9 studies all time

What they study most

Acute Myocardial Infarction (AMI), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Heart Failure, Inflammation, Minimal Change Disease, Obesity, Overweight, Primary Focal Segmental Glomerulosclerosis

Studies at this site

• Study of WAL0921 in Patients With Glomerular Kidney Diseases — Recruiting now
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight — Withdrawn before enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight — Completed
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3) — Completed